Search

Your search keyword '"Younes, Ahmed I."' showing total 39 results

Search Constraints

Start Over You searched for: Author "Younes, Ahmed I." Remove constraint Author: "Younes, Ahmed I."
39 results on '"Younes, Ahmed I."'

Search Results

1. GLI1 -Rearranged Enteric Tumors: Updates on Clinicopathologic and Molecular Genetics Features.

6. Bone morphogenetic protein 7 promotes resistance to immunotherapy

8. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial

10. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

11. Data from SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

12. Supplementary Figures from SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

13. Figure S2 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

14. Supplementary Figures S1, S2, S3 from Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

16. A Quantitative and Qualitative Assessment of Frozen Section Diagnosis Accuracy and Deferral Rate Across Organ Systems

17. High plus low dose radiation strategy in combination with TIGIT and PD1 blockade to promote systemic antitumor responses

19. High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses

20. Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects

23. Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches

24. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

25. SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

26. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity

27. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

28. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer

29. IDO1 Inhibition Overcomes Radiation-Induced “Rebound Immune Suppression” by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

30. Low dose radiotherapy promotes immune-mediated anti-tumor responses

31. Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

32. Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects

33. Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

34. Abstract 1017: Lipid metabolic reprogramming drives resistance to PD1 blockage

36. Targeting anti-PD1-resistant tumors via indoleamine 2,3-dioxygenase 1 (IDO1) inhibition.

37. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

38. High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses

39. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

Catalog

Books, media, physical & digital resources